![Kerry Wentworth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kerry Wentworth
Conseiller Juridique Général chez
NUVATION BIO INC.
Fortune : 253 340 $ au 31/05/2026
Profil
Kerry A. Wentworth is Director at Massachusetts Biotechnology Council since 2019 and Chief Regulatory Officer at Nuvation Bio, Inc. since 2022.
Former roles include Senior Director-Regulatory Affairs at Genelabs Technologies, Inc., Vice President-Clinical, Regulatory & Quality at Agenus, Inc. from 2013 to 2014, Chief Regulatory Officer at Flexion Therapeutics, Inc. from 2017 to 2021, and Head-Regulatory Affairs at Genzyme Corp.
Education includes undergraduate studies at the University of New Hampshire.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/06/2026 | 53 000 ( 0,02 % ) | 253 340 $ | 31/05/2026 |
Postes actifs de Kerry Wentworth
| Sociétés | Poste | Début |
|---|---|---|
| NUVATION BIO INC. | Conseiller Juridique Général | 18/07/2022 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Directeur/Membre du Conseil | 01/04/2019 |
Anciens postes connus de Kerry Wentworth
| Sociétés | Poste | Fin |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Conseiller Juridique Général | 19/11/2021 |
| AGENUS INC. | Directeur Technique/Scientifique/R&D | 10/07/2014 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Conseiller Juridique Général | - |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Conseiller Juridique Général | - |
Formation de Kerry Wentworth
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
Choisissez Zonebourse 
